These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 8286188)
1. Mechanism of action of an orally administered platinum complex [ammine bis butyrato cyclohexylamine dichloroplatinum (IV) (JM221)] in intrinsically cisplatin-resistant human ovarian carcinoma in vitro. McKeage MJ; Abel G; Kelland LR; Harrap KR Br J Cancer; 1994 Jan; 69(1):1-7. PubMed ID: 8286188 [TBL] [Abstract][Full Text] [Related]
2. Comparison of cellular accumulation and cytotoxicity of cisplatin with that of tetraplatin and amminedibutyratodichloro(cyclohexylamine)platinum(IV) (JM221) in human ovarian carcinoma cell lines. Mistry P; Kelland LR; Loh SY; Abel G; Murrer BA; Harrap KR Cancer Res; 1992 Nov; 52(22):6188-93. PubMed ID: 1423261 [TBL] [Abstract][Full Text] [Related]
3. Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates. Kelland LR; Mistry P; Abel G; Loh SY; O'Neill CF; Murrer BA; Harrap KR Cancer Res; 1992 Jul; 52(14):3857-64. PubMed ID: 1617660 [TBL] [Abstract][Full Text] [Related]
4. Cellular pharmacology of cis and trans pairs of platinum complexes in cisplatin-sensitive and -resistant human ovarian carcinoma cells. O'Neill CF; Hunakova L; Kelland LR Chem Biol Interact; 1999 Nov; 123(1):11-29. PubMed ID: 10597899 [TBL] [Abstract][Full Text] [Related]
5. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance. Sharp SY; Rogers PM; Kelland LR Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070 [TBL] [Abstract][Full Text] [Related]
6. In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin. Mellish KJ; Kelland LR; Harrap KR Br J Cancer; 1993 Aug; 68(2):240-50. PubMed ID: 8347478 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of acquired resistance to the orally active platinum-based anticancer drug bis-acetato-ammine-dichloro-cyclohexylamine platinum (i.v.) (JM216) in two human ovarian carcinoma cell lines. Mellish KJ; Kelland LR Cancer Res; 1994 Dec; 54(23):6194-200. PubMed ID: 7954466 [TBL] [Abstract][Full Text] [Related]
8. Circumvention of acquired tetraplatin resistance in a human ovarian carcinoma cell line by a novel trans platinum complex, JM335 [trans ammine (cyclohexylamine) dichloro dihydroxo platinum (IV)]. Mellish KJ; Barnard CF; Kelland LR; Harrap KR Int J Cancer; 1994 Oct; 59(1):65-70. PubMed ID: 7927906 [TBL] [Abstract][Full Text] [Related]
9. DNA-binding properties of novel cis- and trans platinum-based anticancer agents in 2 human ovarian carcinoma cell lines. Mellish KJ; Barnard CF; Murrer BA; Kelland LR Int J Cancer; 1995 Sep; 62(6):717-23. PubMed ID: 7558420 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin. Orr RM; O'Neill CF; Nicolson MC; Barnard CF; Murrer BA; Giandomenico CM; Vollano JF; Harrap KR Br J Cancer; 1994 Sep; 70(3):415-20. PubMed ID: 8080724 [TBL] [Abstract][Full Text] [Related]
11. Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumvention studies using novel platinum (II) and (IV) ammine/amine complexes. Loh SY; Mistry P; Kelland LR; Abel G; Harrap KR Br J Cancer; 1992 Dec; 66(6):1109-15. PubMed ID: 1457352 [TBL] [Abstract][Full Text] [Related]
12. Selective potentiation of platinum drug cytotoxicity in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines by amphotericin B. Sharp SY; Mistry P; Valenti MR; Bryant AP; Kelland LR Cancer Chemother Pharmacol; 1994; 35(2):137-43. PubMed ID: 7987990 [TBL] [Abstract][Full Text] [Related]
13. Ammine/amine platinum(IV) dicarboxylates: a novel class of platinum complex exhibiting selective cytotoxicity to intrinsically cisplatin-resistant human ovarian carcinoma cell lines. Kelland LR; Murrer BA; Abel G; Giandomenico CM; Mistry P; Harrap KR Cancer Res; 1992 Feb; 52(4):822-8. PubMed ID: 1737343 [TBL] [Abstract][Full Text] [Related]
14. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug. Kelland LR; Abel G; McKeage MJ; Jones M; Goddard PM; Valenti M; Murrer BA; Harrap KR Cancer Res; 1993 Jun; 53(11):2581-6. PubMed ID: 8388318 [TBL] [Abstract][Full Text] [Related]
15. Role of carrier ligand in platinum resistance of human carcinoma cell lines. Schmidt W; Chaney SG Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361 [TBL] [Abstract][Full Text] [Related]
16. A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity. Kelland LR; Barnard CF; Mellish KJ; Jones M; Goddard PM; Valenti M; Bryant A; Murrer BA; Harrap KR Cancer Res; 1994 Nov; 54(21):5618-22. PubMed ID: 7923207 [TBL] [Abstract][Full Text] [Related]
17. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin. O'Neill CF; Koberle B; Masters JR; Kelland LR Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725 [TBL] [Abstract][Full Text] [Related]
18. In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473. Holford J; Sharp SY; Murrer BA; Abrams M; Kelland LR Br J Cancer; 1998; 77(3):366-73. PubMed ID: 9472630 [TBL] [Abstract][Full Text] [Related]
19. The cellular basis of the efficacy of the trinuclear platinum complex BBR 3464 against cisplatin-resistant cells. Perego P; Gatti L; Caserini C; Supino R; Colangelo D; Leone R; Spinelli S; Farrell N; Zunino F J Inorg Biochem; 1999 Oct; 77(1-2):59-64. PubMed ID: 10626355 [TBL] [Abstract][Full Text] [Related]
20. Anomalous relationship between cisplatin sensitivity and the formation and removal of platinum-DNA adducts in two human ovarian carcinoma cell lines in vitro. Shellard SA; Hosking LK; Hill BT Cancer Res; 1991 Sep; 51(17):4557-64. PubMed ID: 1873800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]